Barriers to Physical Activity in Patients With Cognitive, Neuromotor or Sensory Impairments During Aging (NO-BARRIERS)

People with disabilities are less physically active than the general population. Their barriers to physical activity are multiple and include intrapersonal, organizational, societal and interpersonal reasons. Nevertheless, at present, the evolution of their barriers to physical activity and the short- and long-term impact of medical and medico-social treatments to limit them are unknown.

The aim of this study is to describe barriers to physical activity, or disability-related underperformance factors in competitive sports, in patients with cognitive, neuromotor or sensory impairments during aging.

Study Overview

Detailed Description

This is an ambispective, monocentric, cohort study of subjects with cognitive, neuromotor or sensory impairments followed in a Physical Medicine and Rehabilitation Department.

All consecutive eligible outpatient subjects consulting to the Parasport Health Unit of the Physical Medicine and Rehabilitation Department of our university hospital will be included. Clinical activities related to the Parasport Health Unit and performed outside the hospital will also be included.

Data will be collected from the patients' medical records, in particular data related to their clinical, radiological, biological and physiological examinations.

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Garches, France, 92380
        • Recruiting
        • Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Subjects with cognitive, neuromotor or sensory impairments.

Description

Inclusion Criteria:

  • Patients >= 6 years old ;
  • Consulting to the Parasport Health Unit of the Physical Medicine and Rehabilitation Department of our university hospital ;
  • Having a neuromotor, cognitive or sensory impairment ;
  • No opposition to be enrolled in the study from the patient, or from a legally authorized close relative if the patient's state of health does not allow it, or from each of the holders of parental authority if a minor ;
  • Affiliation to a social security scheme.

Exclusion Criteria:

  • Under court protection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
All subjects with cognitive impairments
clinical examination, radiological, biological and physiological examinations.
All subjects with neuromotor impairments
clinical examination, radiological, biological and physiological examinations.
All subjects with sensory impairments
clinical examination, radiological, biological and physiological examinations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of barriers to physical activity during aging
Time Frame: through study completion, an average of 1 year
Questionnaires assessing barriers and facilitators to physical activity (ex: BPAQ)
through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of physical activity level during aging
Time Frame: through study completion, an average of 1 year
Questionnaires assessing physical activity levels (ex: PASPID)
through study completion, an average of 1 year
Characteristics of medical and medico-social therapies implemented to limit barriers to physical activity
Time Frame: through study completion, an average of 1 year
Number and description of medical and medico-social therapies
through study completion, an average of 1 year
Characteristics of the medical and medico-social therapies implemented to limit disability-related underperformance factors for competitive sports
Time Frame: through study completion, an average of 1 year
Number and description of medical and medico-social therapies
through study completion, an average of 1 year
Characteristics of devices (orthoses, prostheses, etc.) and technical aids used to facilitate the practice of physical activity
Time Frame: through study completion, an average of 1 year
Number and description of devices (orthoses and prostheses) and technical aids
through study completion, an average of 1 year
Evolution of comorbidities during aging
Time Frame: through study completion, an average of 1 year
Prevalence of comorbidities (e.g. obesity, diabetes, hypertension, sleep apnea, ...)
through study completion, an average of 1 year
Evolution of exercise stress tests results during aging
Time Frame: through study completion, an average of 1 year
Stress tests results
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2022

Primary Completion (Anticipated)

February 1, 2032

Study Completion (Anticipated)

February 1, 2034

Study Registration Dates

First Submitted

January 5, 2022

First Submitted That Met QC Criteria

March 15, 2022

First Posted (Actual)

March 24, 2022

Study Record Updates

Last Update Posted (Actual)

April 19, 2023

Last Update Submitted That Met QC Criteria

April 15, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disability or Chronic Disease Leading to Disablement

Clinical Trials on standard of care for patients with cognitive impairments

3
Subscribe